MedPath
HSA Approval

RENNIE TABLET

SIN08733P

RENNIE TABLET

RENNIE TABLET

May 27, 1996

BAYER (SOUTH EAST ASIA) PTE LTD

BAYER (SOUTH EAST ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAYER (SOUTH EAST ASIA) PTE LTD
Licence HolderBAYER (SOUTH EAST ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AD01

ordinary salt combinations

Manufacturer Information

BAYER (SOUTH EAST ASIA) PTE LTD

Delpharm Gaillard

Active Ingredients

CALCIUM CARBONATE

680 mg

Calcium carbonate

MAGNESIUM CARBONATE HEAVY

80 mg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.